PIS
PFE icon

POM Investment Strategies’s Pfizer PFE Stock Holding History

POM Investment Strategies’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$72.2K Sell
3,000
-2,774
-48% -$72.6K 0.08% 73
2026
Q1 		$162K Buy
5,774
+5,376
+1,351% +$143K 0.2% 58
2025
Q4 		$9.91K Buy
398
+123
+45% +$3.1K 0.01% 150
2025
Q3 		$7.01K Buy
+275
New +$6.79K ﹤0.01% 129
2025
Q2 		– Sell
-1,506
Closed -$38.2K – 202
2025
Q1 		$38.2K Buy
+1,506
New +$39.4K 0.04% 58

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

POM Investment Strategies's PFE Position: Q2 2026 in Review

POM Investment Strategies reduced its Pfizer (PFE) stake by 48% in Q2 2026, selling an estimated $72.6K and leaving 3,000 shares worth $72.2K. The position accounts for 0.08% of the portfolio, ranked #73.

POM Investment Strategies first reported a position in PFE in Q1 2025 and has held it in 5 quarters since. The position peaked at $162K in Q1 2026. 2,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • POM Investment Strategies held 3,000 shares of Pfizer worth $72.2K as of Q2 2026.
  • POM Investment Strategies sold 2,774 Pfizer shares in Q2 2026, an estimated $72.6K.
  • Pfizer made up 0.08% of POM Investment Strategies's portfolio in Q2 2026, its #73 holding.
  • POM Investment Strategies first reported a position in Pfizer in Q1 2025 and has held it in 5 quarters since.
  • POM Investment Strategies's Pfizer position peaked at $162K in Q1 2026.
  • 2,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on POM Investment Strategies's 13F filing for Q2 2026, filed 31 Jul 2026.